Skip to main content
. 2018 Aug 1;7(1):116–122. doi: 10.1089/biores.2017.0040

Table 1.

Baseline Characteristics in Polycystic Ovary Syndrome Women With or Without Central Obesity

  Central obesity (n = 70) Noncentral obesity (n = 118)
No. of cycles 70 118
Age (years) 30.2 ± 3.5 29.5 ± 3.5
Duration of infertility (years) 5.38 ± 3.28 4.76 ± 3.15
Primary infertility (n, %) 42 (60.0) 72 (61.0)
Cause of infertility (n)
 PCOS 20 28
 PCOS and tubal factor 38 64
 PCOS and male factor 10 20
 PCOS and endometriosis 2 6
Times of cycle 1.21 ± 0.41 1.16 ± 0.37
PCOS phenotypes
 HA, OAD, and PCOM 39 (55.7) 53 (44.9)
 HA and OAD without PCOM 13 (18.6) 17 (14.4)
 HA and PCOM with ovulatory cycles 4 (5.7) 16 (13.6)
 OAD and PCOM without HA 14 (20.0) 32 (27.1)
 BMI (kg/m2) 24.9 ± 2.2* 20.4 ± 2.4*
 Waist circumference (cm) 86.1 ± 6.2* 71.0 ± 4.4*
 Hip circumference (cm) 97.5 ± 6.4* 89.3 ± 4.2*
 Waist–hip ratio 0.88 ± 0.06* 0.80 ± 0.05*
 Basal FSH (IU/L) 7.21 ± 2.82 7.32 ± 2.30
 Basal LH (IU/L) 7.90 ± 5.13 8.09 ± 5.32
 Basal TT (nmol/L) 2.03 ± 0.72 2.14 ± 0.87
 FT (pg/mL) 3.92 ± 2.37 3.11 ± 2.35
 FAI 5.73 ± 4.73* 3.17 ± 2.47*
 DHEA-S (ng/mL) 2231.4 ± 983.6 2200.4 ± 1077.1
 SHBG (nmol/L) 57.8 ± 44.8* 103.4 ± 85.1*
 Serum fasting glucose (mmol/L) 5.35 ± 0.78** 5.08 ± 0.44**
 Serum fasting insulin (mU/L) 11.63 ± 7.17* 6.34 ± 3.63*
 HOMA-IR 2.87 ± 2.44* 1.44 ± 0.84*
 Insulin resistance (n, %) 45 (64.3)* 20 (16.9) *
 2-h glucose (mmol/L) 8.38 ± 3.03* 6.54 ± 2.14*
 2-h insulin (mU/mL) 111.98 ± 68.36* 64.26 ± 47.65*
 IFG (n, %) 17 (24.3)** 14 (11.9)**
 IGT (n, %) 17 (24.3)** 13 (11.0)**
 Type II DM (n, %) 8 (11.4) 4 (0.3)
 CHOL (mmol/L) 5.11 ± 0.50 4.83 ± 0.90
 TG (mmol/L) 2.70 ± 2.30* 1.25 ± 0.65*
 HDL-C (mmol/L) 1.37 ± 1.35** 1.52 ± 0.27**
 LDL-C (mmol/L) 3.10 ± 0.68 2.80 ± 0.85
 Volume of left ovary (mL) 7.68 ± 5.92 7.23 ± 3.17
 Volume of right ovary (mL) 7.46 ± 6.13 7.82 ± 4.34
 AFC 25.8 ± 9.1 25.8 ± 8.5

Values are expressed as mean ± SD or numbers (percentages).

*

Significant differences between two groups, p < 0.01.

**

Significant differences between two groups, p < 0.05.

PCOS, polycystic ovary syndrome; PCOM, polycystic ovarian morphology; HA, hyperandrogenism; OAD, oligoanovulatory ovarian dysfunction; BMI, body mass index; FSH, follicle-stimulating hormone; LH, luteinizing hormone; TT, total testosterone; FT, free testosterone; FAI, free androgen index; DHEA-S, dehydroepiandrosterone sulfate; SHBG, sex hormone-binding globulin; HOMA-IR, homeostatic model assessment for insulin resistance; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; DM, diabetes mellitus; CHOL, cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; AFC, antral follicle count; SD, standard deviation.